Evaluation and validation of biomarkers in granulomatosis with polyangiitis and microscopic polyangiitis

10.1136/annrheumdis-2013-203255

10.1093/rheumatology/ker280

10.1016/j.autrev.2013.11.003

10.1093/rheumatology/kei272

10.1136/ard.2008.094714

10.1681/ASN.2013111233

Lally L , Spiera RF . Biomarkers in ANCA-associated vasculitis. Curr Rheumatol Rep 2013; 15: 363

10.1097/BOR.0000000000000009

10.1136/annrheumdis-2012-201981

10.1002/art.30615

10.2215/CJN.02790313

10.1159/000323393

10.1186/ar3873

10.1681/ASN.2010080858

Moosig, 1998, Elevated procalcitonin levels in active Wegener's granulomatosis, J Rheumatol, 25, 1531

10.1007/BF02962246

10.1002/art.1780350914

10.1016/S0002-9343(96)00230-6

Bruchfeld, 2011, High-mobility group box-1 protein (HMGB1) is increased in antineutrophilic cytoplasmatic antibody (ANCA)-associated vasculitis with renal manifestations, Mol Med, 17, 29, 10.2119/molmed.2010.00132

10.3899/jrheum.100302

10.1136/ard.2005.040980

10.1161/01.CIR.0000124720.18538.DD

West, 1997, Serum hyaluronan levels follow disease activity in vasculitis, Clin Nephrol, 48, 9

10.1093/ndt/gfq506

10.1136/ard.2007.076547

10.1002/art.20002

10.1093/ndt/gfp783

10.1038/ki.2012.313

10.3899/jrheum.120879

10.1093/ndt/gfh487

Ohlsson, 2009, Monocyte chemoattractant protein 1 is a prognostic marker in ANCA-associated small vessel vasculitis, Mediators Inflamm, 2009, 584916, 10.1155/2009/584916

10.1602/neurorx.1.2.182

10.1093/rheumatology/keq400

10.1681/ASN.2013020143

10.1160/TH14-11-0921

10.1371/journal.pone.0087857

10.1186/ar3912

10.1136/ard.2009.119172

10.1186/ar4284

10.1093/ndt/gfn755

10.1371/journal.pone.0030197